In the VISEP trial there was also an overall trend toward increased mortality among HES 200/0.5 recipients (Fig. 2 ).
← all excerpts
Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis.
1
—
—